Sanara MedTech berbalik rugi GAAP jadi USD 0,4 juta pada Q2 FY26; revenue naik 9% jadi USD 28,1 juta

Reuters2026/08/11 20:22

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sanara Medtech membukukan net revenue kuartal II 2026 naik 9% menjadi USD 28,1 juta, berbalik menjadi rugi bersih berlanjut USD 0,4 juta.
Operating income turun menjadi USD 1,8 juta; Adjusted EBITDA (non-GAAP) naik menjadi USD 5 juta.
Gross margin naik 1 poin persentase menjadi 93%; beban operasi naik 14% menjadi USD 24,4 juta.
Perusahaan mengaitkan kenaikan beban dengan biaya penjualan-pemasaran, kompensasi, serta jasa hukum dan penasihat untuk inisiatif strategis.
Seth Yon mengatakan Sanara masuk kesepakatan transformasional untuk diakuisisi MIMEDX; OsStic ditargetkan meluncur kuartal I 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanara Medtech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608111610PRIMZONEFULLFEED9807935) on August 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sanara MedTech berbalik rugi GAAP jadi USD 0,4 juta pada Q2 FY26; revenue naik 9% jadi USD 28,1 juta

You may also like

Crypto prices